JW Pharmaceutical (XKRX:001065.PFD) Net Change in Cash : ₩5,654.20 Mil (TTM As of Sep. 2024)

View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

JW Pharmaceutical's Net Change in Cash for the three months ended in Sep. 2024 was ₩5,492.48 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 was ₩5,654.20 Mil.

JW Pharmaceutical Net Change in Cash Historical Data

The historical data trend for JW Pharmaceutical's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Net Change in Cash Chart

JW Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

10,915.83

-31,412.91

22,915.14

531.45

-17,989.06

JW Pharmaceutical Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Change in Cash	Get a 7-Day Free Trial															17,205.96	-17,211.77	16,775.16	598.33	5,492.48

JW Pharmaceutical Net Change in Cash Calculation

JW Pharmaceutical's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	87157.236	+	-63780.27	+	-41245.329	+	-120.694
	=	-17,989.06

JW Pharmaceutical's Net Change in Cash for the quarter that ended in Sep. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 10833.705 + 10288.664 + -15360.018 + -269.874

= 5,492.48

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩5,654.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW Pharmaceutical Net Change in Cash Related Terms
Thank you for viewing the detailed overview of JW Pharmaceutical's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

JW Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001065.PFD) » Definitions » Net Change in Cash

Comparable Companies

XKRX:220100 XKRX:000640 XKRX:019170 XKRX:170900 XKRX:084110 XKRX:206650 XKRX:200670 XKRX:003520 XKRX:086450 XKRX:082800 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692

Traded in Other Exchanges

001067:Korea 001060:Korea

Address

2477, Nambusunhwan-ro, Seocho-gu, KOR

Website

https://www.jw-pharma.co.kr

JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical Headlines

No Headlines